We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics
News

Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics

Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics
News

Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Beckman Coulter, Inc. has announced it has entered into an agreement to sell the company's minority interest in Agencourt Personal Genomics (APG).

This follows from an agreement between APG and Applied Biosystems Group, an Applera Corporation business whereby Applied Biosystems will acquire APG subject to regulatory and other customary closing conditions.

Beckman Coulter acquired shares of APG in conjunction with its acquisition of Agencourt Bioscience in May 2005.

Beckman Coulter expects to receive about $50 million in cash from the transaction which is anticipated to close in the third quarter of 2006.

Advertisement